Navigation Links
Moffitt Cancer Center: Growing interest in prognostic test for non-small cell lung cancer
Date:4/26/2010

Tampa, FL (April 23, 2010) Moffitt Cancer Center announces steadily growing interest in the ERCC1 Analysis, the first test developed for selecting chemotherapy for Non Small Lung Cancer patients. Each year, more than 200,000 Americans are diagnosed with lung cancer.

The ERCC1 Analysis measures ERCC1 levels in cells to predict response to cisplatin-based chemotherapy. The correlation between ERCC1 levels and therapy response was discovered at Moffitt Cancer Center and exclusively licensed to Genzyme Corporation in November of 2007. Genzyme Genetics, a business unit of Genzyme Corporation, officially launched the ERCC1 Analysis on May 1, 2009.

Several studies1-6 have shown that evaluating the expression levels of excision repair cross-complementation group 1 (ERCC1) may help physicians identify patients that may benefit from platinum-based chemotherapy - currently considered the standard of care in advanced NSCLC. Specifically, low expression levels of ERCC1 have been related to a better response and survival benefit from adjuvant cisplatin-based chemotherapy.

"We are very pleased that many medical oncologists have begun utilizing this lung cancer test to better identify chemotherapy for non small cell lung cancer patients," said Jarett Rieger, Director of the Office of Technology Management and Licensing at Moffitt. "This test is an example of personalized medicine emanating from Moffitt Cancer Center, and as a result of our licensing partnership with Genyzme this test can now benefit lung cancer patients."

"The ERCC1 test complements our growing menu of personalized tests that predict response to treatment in NSCLC, said Celeste Chenet-Monte, Director Marketing, Oncology at Genzyme Genetics. "Other tests on our menu include EGFR and KRAS mutation analysis, ALK gene rearrangements and EGFR amplification, all of which can be used for prediction of response to targeted therapies used to treat patients with ad
'/>"/>

Contact: Michelle Foley
Michelle.Foley@moffitt.org
813-745-1505
H. Lee Moffitt Cancer Center & Research Institute
Source:Eurekalert

Page: 1 2

Related biology news :

1. Moffitt Cancer Center signs licensing agreement with Proteacel, LLC
2. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
3. A study by the MUHC and McGill University opens a new door to understanding cancer
4. ESF EURYI award winner aims to stop cancer cells reading their own DNA
5. Protein chatter linked to cancer activation
6. Newly created cancer stem cells could aid breast cancer research
7. Western diet linked to increased risk of colon cancer recurrence
8. Obesity and lack of exercise could enhance the risk of pancreatic cancer
9. Low levels of key protein may indicate pancreatic cancer risk
10. Birth records hold pancreatic cancer clue
11. Many parents at-risk for cancer disclose genetic test results to children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... scientists have discovered that scorpions create a platform in ... hunt. , As ectothermic animals, scorpions rely on ... researchers believe that this platform provides a safe, warm ... before they leave their hiding places to forage at ... ( Scorpio maurus palmatus ) in Israel,s Negev desert ...
(Date:7/10/2014)... Amyloid diseases, such as Alzheimer,s disease, type ... share the common trait that proteins aggregate into ... vitro studies have found that neither the amylin ... toxic. New evidence using two-dimensional infrared (2D IR) ... amylin aggregation pathway that may explain toxicity, opening ...
(Date:7/10/2014)... Satellite or GOES-West satellite spotted smoke over the ... Canada,s Northwestern Territories. , At 1200 UTC (8 ... this image of the brownish-colored haze created by ... all the way into South Dakota. This image ... NASA Goddard Space Flight Center, Greenbelt, Md. ...
Breaking Biology News(10 mins):Scorpions are master architects, according to new research from Ben-Gurion University 2New technology reveals insights into mechanisms underlying amyloid diseases 2
... standard laboratory conditions, the human beta-defensin 1 (hBD-1), a ... shown only little activity against microbes. Nevertheless the human ... the puzzle was the investigation process itself, as the ... Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology of the ...
... 21, 2011 Cancer Research Institute, Inc. (CRI), a ... science of tumor immunology and foster the discovery and ... Cancer Vaccine Acceleration Fund (CVAF), a joint initiative with ... completed a new investment agreement with Oncovir, Inc., a ...
... network in Mauritania, on the north west coast of ... as well as being home to two of the ... monk seal and the Atlantic hump-backed dolphin. The results ... activities along the coast are putting these mammals and ...
Cached Biology News:Defense mechanism against bacteria and fungi deciphered 2Cancer Research Institute invests $450k in Oncovir to manufacture powerful immune stimulant 2Cancer Research Institute invests $450k in Oncovir to manufacture powerful immune stimulant 3Monk seal and hump-backed dolphin are threatened by fishing activities off coast of Mauritania 2
(Date:7/10/2014)... (PRWEB) July 10, 2014 Terascala, the ... announced that Alan Swahn, a former vice president of ... team as vice president of marketing. Terascala’s software when ... and NetApp create the highest performance and most reliable ... appointed to guide Terascala’s channel expansion and broaden its ...
(Date:7/10/2014)... Robert Harman, DVM, Founder and CEO of Vet-Stem, Inc., ... the relaunch of his highly informative blog, now named Stem ... What are Stem Cells ?” Dr. Harman’s purpose for ... the basics of stem cell therapy so that pet owners ... treatment when considering regenerative medicine. , A veterinarian by trade, ...
(Date:7/10/2014)... EvoDerma ’s NOOME Anti-Aging Motion has ... now comes with a second treatment cup to help prevent ... new cup is thinner on the edges for a softer ... thin and uneven surfaces on the face, neck and décolleté. ... treatment on areas such as the cheeks and neck, or ...
(Date:7/10/2014)... 10, 2014  Franciscan St. Anthony Health-Crown ... for respiratory monitoring outside the operating room, ... in embracing state-of-the-art patient safety technology. ... breathing and can alert medical caregivers when ... amount of carbon dioxide the patient is ...
Breaking Biology Technology:Terascala Expands Executive Team 2Terascala Expands Executive Team 3Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography 2
... Research has shown that certain marginalized groups including ... as African Americans and Latinos fare worse than ... impoverishment, injuries and fatalities. , Now, ... found that they also experience greater terrorism-related fears and ...
... an early warning system for potential ecological disasters, ... Stockholm University and the University of East Anglia. ... food production are of fundamental importance for all ... changes in ecosystems caused by various pressures like ...
... Receives Positive Committee Recommendation in European UnionSAN MATEO, Calif., ... ), a biopharmaceutical company focused on developing and commercializing ... a conference call on Friday, March 20, 2009 at ... quarter and year-end 2008 results and the European Medicines ...
Cached Biology Technology:Disabled and other vulnerable groups more susceptible to terrorism fears 2Internet can warn of ecological changes 2Internet can warn of ecological changes 3NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Year-End 2008 Financial Results and European Regulatory Update 2NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Year-End 2008 Financial Results and European Regulatory Update 3NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Year-End 2008 Financial Results and European Regulatory Update 4